Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

International Pharmaceutical Products

Executive Summary

The Costa Mesa, Calif.-based generic firm announced the formation of a new opthalmic products subsidiary, American Pharmaceuticals Inc. The subsidiary, which will be spun-off to International Pharmaceutical shareholders, will be comprised of the company's ophthalmic products division and Maurry Biological. The new Structure, International Pharmaceutical said, will allow it "to concentrate on its major areas of interest, which are new product development (hyaluronic acid, anti-ulcer and chemotherapy drugs) and generic oncology product sales".
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS011501

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel